Company / Operating Cash Flow per Share
IONIS PHARMACEUTICALS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.70
FY2025
5-year range
-$3.47 / $2.46
FY2021-FY2025
Trend
+51.0%
vs FY2024
Sector context
#137 of 212
Health Care
What the data says
At $-1.70, IONIS PHARMACEUTICALS INC's operating cash flow per share ranks #137 of 212 in the Health Care sector. Operating Cash Flow per Share returned to growth in FY2025 after 4 years of decline, reaching $-1.70.
Based on SEC 10-K filings.
-1.70 in FY2025.
Improved from $-2.16 to $-1.70 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#137 of 212 in Health CareTop 65% of 212This company -$1.70 Sector average $5.28
▼
-132.2% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 51.0% year-over-year.
- Ranks #137 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.70 | +51.0% |
| FY2024 | -$3.47 | -60.3% |
| FY2023 | -$2.16 | -11.4% |
| FY2022 | -$1.94 | -178.9% |
| FY2021 | $2.46 | -42.7% |
| FY2020 | $4.30 | +240.3% |
| FY2019 | $1.26 | +240.8% |
| FY2018 | -$0.90 | -162.7% |
| FY2017 | $1.43 | +253.7% |
| FY2016 | -$0.93 | -622.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026